UNC Lineberger faculty will be presenting study findings and discussing clinical and research developments at the 2019 San Antonio Breast Cancer Symposium on Dec. 10-14. The annual scientific meeting brings together breast cancer researchers and clinicians from around the world and features talks on the latest developments in breast cancer research, from the laboratory to the clinic to the community, including diagnosis, treatment and prevention.
Among those presenting at the meeting include:
Patty Spears, patient research advocate and scientific research manager at UNC Lineberger’s Office of Clinical and Translational Research and chair of the Patient Advocates for Research Council, will share her perspective on how to talk with patients about participating in clinicals.
Charles Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology in the UNC School of Medicine, will speak at an educational session on tailoring adjuvant therapies based on neoadjuvant response, “The biology and plasticity of residual disease after neoadjuvant treatment.”
Katherine Reeder-Hayes, MD, MBA, MSc, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, is chairing a discussion session on Toxicity, Tolerability & Cost and will speak on socioeconomic status, symptoms and treatment discontinuation.
Katherine A Hoadley, PhD, assistant professor of genetics in the UNC School of Medicine, will present findings from a large national breast cancer study that investigated whether recurrently mutated genes in triple negative breast cancer is associated with treatment response, “Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance).”
Lawrence Marks, MD, the Dr. Sidney K. Simon Distinguished Professor of Oncology Research and chair of radiation oncology at UNC School of Medicine, will participate in a debate on whether mastectomy should be offered to patients who are breast conservation candidates when modern radiotherapy is available.